Skip to main content
[Preprint]. 2023 Sep 11:rs.3.rs-2248327. Originally published 2022 Dec 2. [Version 2] doi: 10.21203/rs.3.rs-2248327/v2

Figure 4. Binding affinities of the SARS-CoV-2 potential variants (PVs) for the Fc-ACE2 receptor three neutralizing antibodies as measured by biolayer interferometry (BLI).

Figure 4.

Binding affinities of the indicated RBD to Fc-ACE2 and the neutralizing antibodies as analyzed by biolayer interferometry (BLI).